-
EPL Pathologists Share Expertise at the 1st Southwest China Regional Toxicologic Pathology Workshop/Slide-Reading Seminar
0On March 4, 2016, Dr. Peter Mann and Dr. Paul Snyder from EPL participated in the 1st Southwest China Regional Toxicologic Pathology Workshop/Slide-Reading Seminar. Dr. Mann and Dr. Snyder organized and developed the seminar to provide education for Asian Toxicologists and Pathologists on study design …
Read More -
EPL, Inc. Opens a Northeast Office in Collegeville, Pennsylvania
Experimental Pathology Laboratories, Inc. (EPL®) established EPL Northeast on February 8, 2016. This office is headed by Dr. Heath Thomas who was formerly Vice President of Safety Assessment at GlaxoSmithKline. The Northeast office is located outside of Philadelphia at 125 Chinaberry Lane, Collegeville, PA. With …
Read More 
EPL Participates in SETAC Pellston Workshop for Risk Assessment Approaches for Endocrine-Active Chemicals
Dr. Jeff Wolf, EPL CSO and Manager of Pathology at the Virginia Laboratory, participated in a SETAC-Pellston Workshop™ entitled “”Environmental Hazard and Risk Assessment Approaches for Endocrine-Active Chemicals (EHRA): Developing Technical Guidance based on case studies to Support Decision Making.” The workshop was held in …
Read More
EPL Activities at the 55th Annual Meeting of the Society of Toxicology (SOT)
EPL will once again be exhibiting at ToxExpo™ in New Orleans from March 14-16, 2016. If you are attending the 55th Annual Society of Toxicology Meeting, please visit our team; we will be exhibiting in Booth #1319. Dr. Gabrielle is an author of the poster, …
Read More
Meet Aclairo Pharmaceutical Development Group
Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together. On …
Read More
Experimental Pathology Laboratories, Inc. (EPL) Acquires Aclairo Pharmaceutical Development Group, Inc.
EPL and Aclairo Combine Preclinical Services Expertise EPL is pleased to announce that it has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo) which provides independent and objective nonclinical, regulatory, and clinical ADME/DMPK expert strategy and implementation to the pharmaceutical and drug device industries. “Aclairo’s team …
Read More-
2015: Year in Review
It certainly was an eventful year at Experimental Pathology Laboratories, Inc. (EPL) again in 2015! Here’s what you may have missed………. EPL continues to add expertise in pathology by establishing a California site headed by Dr. Ted Birkebak in the San Francisco Bay Area to …
Read More 
EPL Pathologist Presents Seminar on Zebrafish Pathology
Dr. Jeff Wolf, Chief Scientific Officer at EPL, presented a seminar entitled, “Zebrafish Pathology in the Omics Era,” for the Cellular and Molecular Pathology Branch of the NIEHS on Wednesday, December 9, 2015. The goal of the seminar was to demonstrate the continued relevance of …
Read More
Tox Path Textbook Prize Winners at the Society of Toxicologic Pathology (STP) Trainee Mixer
EPL awarded two copies of a textbook, Toxicologic Pathology: Nonclinical Safety Assessment, as prizes at the Trainee Mixer during the 2015 ACVP/ASVCP/STP Combined Annual Meeting in Minneapolis. We are happy to announce that Renee Girens and Shannon Roff were the winners of the textbooks. Renee …
Read More
EPL Necropsy Teams Capable of Providing Specialized DART Necropsies
We are pleased to announce that EPL’s necropsy teams have received specialized training in support of Developmental and Reproductive Toxicology (DART) necropsies. Training in techniques used for DART studies was provided by Dr. Stephen Harris at Smithers Avanza Toxicology Services. DART training is focused primarily …
Read More
